Regulatory Filing & Pre- License/Pre-Approval Inspections of ...

More documents

Recommendations

Info

Acknowledgements• Patricia Hughes, Ph.D.• Kalavati Suvarna, Ph.D.• Bo Chi, Ph.D.Thank you!42
Contact InformationAnastasia Lolas301-796-1566anastasia.lolas@fda.hhs.gov43
Page 1 and 2: Regulatory Filing & Pre-License/Pre
Page 3 and 4: Regulatory Authority3
Page 6: 21 CFR Part 601 - LicensingRelevant
Page 9 and 10: “Specified” Biological Products
Page 11 and 12: 21 CFR 601.20 - Biologics licenses;
Page 13 and 14: Organization13
Page 16 and 17: Division of Manufacturing and Produ
Page 18 and 19: BMT Review of a BLADrug Substance
Page 20: BMT Review of a BLADrug Product (co
Page 23 and 24: Review Issues‣ Bulk thaw & hold l
Page 25 and 26: Purpose of Inspection‣Meet statut
Page 27 and 28: Inspection StrategySystems-based‣
Page 29 and 30: Inspection Outcome & Approval‣A r
Page 31 and 32: Quality Oversight‣Inadequate qual
Page 33 and 34: SOPs‣ SOPs are not executed consi
Page 35 and 36: Utilities‣High bioburden counts f
Page 37 and 38: Production‣Discrepancies between
Page 39 and 40: Laboratory‣Assays not appropriate
Page 41: Additional Information/Resources‣

Regulatory Filing & Pre- License/Pre-Approval Inspections of ...

Create successful ePaper yourself

Delete template?

Save as template?